Based on the correlation of reduced numbers of CCR6+ ILC2s in the blood circulation of CF patients with enhanced lung inflammation and the previously described presence of pathologically increased CCL20 levels in CF BAL (15), we postulate the CCR6 - CCL20-driven ILC2 lung homing mechanism to be important in driving CF lung pathology. The gene discussed is CCR6; the disease is cystic fibrosis.